![Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology](https://www.thelancet.com/cms/attachment/7a920242-050b-49bd-a25d-a1e4b38371ca/gr1_lrg.jpg)
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
![Biclonal Gammopathy of Iga Kappa Variant in a Patient with Systemic Lupus Erythematosus: A Case Report Biclonal Gammopathy of Iga Kappa Variant in a Patient with Systemic Lupus Erythematosus: A Case Report](http://clinmedjournals.org/articles/cmrcr/cmrcr-8-353-002.jpg)
Biclonal Gammopathy of Iga Kappa Variant in a Patient with Systemic Lupus Erythematosus: A Case Report
![Immunoglobulin G(κ) [IgG(κ)] and IgG(λ) Paraproteinemia in a Child with AIDS and Response to Highly Active Antiretroviral Therapy | Clinical and Vaccine Immunology Immunoglobulin G(κ) [IgG(κ)] and IgG(λ) Paraproteinemia in a Child with AIDS and Response to Highly Active Antiretroviral Therapy | Clinical and Vaccine Immunology](https://journals.asm.org/cms/10.1128/CDLI.12.11.1331-1333.2005/asset/bc222f07-4d6e-4668-a88e-a94e715a7412/assets/graphic/zcd0110526090001.jpeg)
Immunoglobulin G(κ) [IgG(κ)] and IgG(λ) Paraproteinemia in a Child with AIDS and Response to Highly Active Antiretroviral Therapy | Clinical and Vaccine Immunology
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
![Frontiers | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells Frontiers | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells](https://www.frontiersin.org/files/Articles/620427/fimmu-12-620427-HTML/image_m/fimmu-12-620427-g001.jpg)
Frontiers | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells
![Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft | BMC Nephrology | Full Text Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-019-1239-8/MediaObjects/12882_2019_1239_Fig2_HTML.png)
Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft | BMC Nephrology | Full Text
![The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | Nature Reviews Nephrology The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-018-0077-4/MediaObjects/41581_2018_77_Fig1_HTML.png)
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | Nature Reviews Nephrology
![Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias](https://www.degruyter.com/document/doi/10.1515/cclm-2015-0580/asset/graphic/j_cclm-2015-0580_fig_001.jpg)
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
![Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients | Leukemia Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2012.197/MediaObjects/41375_2013_Article_BFleu2012197_Fig1_HTML.jpg)
Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients | Leukemia
![Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains](https://www.degruyter.com/document/doi/10.1515/cclm-2016-0364/asset/graphic/j_cclm-2016-0364_fig_002.jpg)